Project Description
CSW Therapeutics is using the power of focused soundwaves to treat refractory angina, a chronic condition in no-option coronary artery disease patients who suffer from long-lasting symptoms due to ischaemia.
Using recurring & personalized focused soundwave therapy, CSW Therapeutics stimulates myocardial tissue on a cellular level, inducing a regenerative and angiogenic effect in myocardial tissue, leading to improved ventricular function and quality of life.
CSW Therapeutics joined NOME in 2024.